RxDoctor Payments Data

Fabian Laage Gaupp, MD

Vascular & Interventional Radiology · New Haven, CTNPI 1396130126

Payments from drug & device makers

What this record shows

Boston Scientific accounts for 66.9% of it on its own, with 6 other manufacturers making up the rest.

$7,838in general payments, 2019–2025

Across 57 payments — averaging $137.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$5K
  • Inari Medical, Inc.$2K
  • Stryker$372
  • Medtronic$331
  • Mediview XR, Inc.$166
  • Terumo Medical Corporation$109
  • plus $58 from 1 others

What the payments were for

  • Travel & lodging$4,15353%
  • Food & beverage$3,68547%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific19$5,246
Inari Medical, Inc.26$1,554
Stryker5$372
Medtronic3$331
Mediview XR, Inc.1$166
Terumo Medical Corporation2$109
Argon Medical Devices, Inc.1$58

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,838 in reported general payments places this provider in the 70th percentile of 50 vascular & interventional radiology providers in Connecticut.

See all vascular & interventional radiology providers in Connecticut

Medicare billing

Part B allowed, 2024
$51,717
Medicare patients
185
Services billed
535

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin Hcl14$111
Ibuprofen18$106
Oxybutynin Chloride16$66

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →